Rethinking the rise of early-onset gastrointestinal cancers: a call to action
- PMID: 39814070
- PMCID: PMC11804804
- DOI: 10.1093/jncics/pkaf002
Rethinking the rise of early-onset gastrointestinal cancers: a call to action
Abstract
Since the early 1990s, there has been a dramatic rise in gastrointestinal cancers diagnosed in patients under age 50 for reasons that remain poorly understood. The most significant change has been the increase in incidence rates of early-onset colorectal cancer, especially rates of left-sided colon and rectal cancers. Increases in gastric, pancreatic, and other gastrointestinal cancer diagnoses have further contributed to this trend. We formed a multidisciplinary Think Tank to develop a strategic, coordinated approach to studying early-onset gastrointestinal cancers. This area of research is challenging given multifactorial etiologies. We focused on epidemiology and the environment, the microbiome, and survivorship as key pillars to structure a research framework. We advocate a comprehensive strategy to (1) use existing biospecimens, especially those collected longitudinally, with correlation to exposures (the exposome); (2) standardize microbiome specimen collection and analyses of blood, tissue, and stool specimens to minimize contamination and biases; (3) prioritize mechanistic studies to evaluate findings from biomarker studies; and (4) explore the unique survivorship needs of this young population. These recommendations build upon prior efforts with the goal of streamlining research into this important field of study while minimizing redundant efforts. We hope that our findings serve as a clarion call to motivate others to discover why young individuals are being diagnosed with gastrointestinal cancers at such an alarming rate and how to best support those who have been diagnosed.
© The Author(s) 2025. Published by Oxford University Press.
Conflict of interest statement
The authors have no relevant conflicts of interest.
Figures


Similar articles
-
Early-Onset Cancer in the Gastrointestinal Tract Is on the Rise-Evidence and Implications.Cancer Discov. 2023 Mar 1;13(3):538-551. doi: 10.1158/2159-8290.CD-22-1038. Cancer Discov. 2023. PMID: 36757194 Review.
-
The TEOGIC study project: a comprehensive characterization of early onset gastrointestinal cancer in the Northern area of Spain.BMC Cancer. 2024 Jun 1;24(1):668. doi: 10.1186/s12885-024-12454-9. BMC Cancer. 2024. PMID: 38824512 Free PMC article.
-
The microbiome and rise of early-onset cancers: knowledge gaps and research opportunities.Gut Microbes. 2023 Dec;15(2):2269623. doi: 10.1080/19490976.2023.2269623. Epub 2023 Oct 30. Gut Microbes. 2023. PMID: 37902043 Free PMC article. Review.
-
Updated epidemiology of gastrointestinal cancers in East Asia.Nat Rev Gastroenterol Hepatol. 2023 May;20(5):271-287. doi: 10.1038/s41575-022-00726-3. Epub 2023 Jan 11. Nat Rev Gastroenterol Hepatol. 2023. PMID: 36631716 Review.
-
Burden of gastrointestinal cancers among people younger than 50 years in China, 1990 to 2019.Public Health. 2024 Sep;234:112-119. doi: 10.1016/j.puhe.2024.06.008. Epub 2024 Jul 6. Public Health. 2024. PMID: 38972229
References
-
- Ben-Aharon I, Laarhoven H, Fontana E, et al. Early-onset cancer in the gastrointestinal tract is on the rise-evidence and implications. Cancer Discov. 2023;13:538-551. - PubMed
-
- Surveillance, Epidemiology, and End Results (SEER) Program. SEERStat Database: incidence—SEER Research Plus Data, 12 Registries, Nov 2023 Sub (1992-2021)—linked to county attributes—total U.S., 1969-2022 counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2024, based on the November 2023 submission. 2024. www.seer.cancer.gov
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous